In this fifth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC ...
An analysis estimates Trump increased his stock holdings from $1.7 million in 2024 to up to $56.2 million last year.
Study: Patient, consumer reps at FDA adcomms increasingly hold ties to pharma-backed advocacy groups
At some advisory committee meetings, more than half of patient and consumer representatives who attended had connections to ...
Shares of pharma firm Laurus Labs are set for a 25% upside from the market price of Rs 2020 in the next one year, says ...
The advantage comes from bringing all three into a disciplined decision process. Executives must recognize when experience ...
Revolution Medicines is laying the groundwork for a broad European commercial rollout of its pancreatic cancer drug, ...
BioSpectrum India on MSN
Indian pharma market records 13.5% value growth, volume growth rises to 3% in September 2026
September 2026 performance marks a notable improvement in volume growth ...
It became clear at the Health Data Summit the FDZ is to be a European giant with AI and ePA data. But there are issues with ...
In this fourth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC ...
Optimize ROI through targeted marketing, product innovation, competitive intelligence, regulatory readiness, strategic investments, partnerships, and M&A opportunities.Dublin, Oct. 14, 2026 (GLOBE ...
In today’s Pharmaceutical Executive Daily, Gilead and Vir Biotechnology enter a collaboration worth up to $1.87 billion to ...
The marked differences of how a JAK inhibitor and an anti-IL-4 inhibitor affect proteomics in the treatment of AD provide new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results